Gastroscopy Clinical Trial
Official title:
Effect of Bispectral Index Monitoring and Observer's Assessment Alert Sedation Scale (OAA/S) Guided Sedation on Body Movement of Outpatients Undergoing Gastroscopy: a Randomized Study
Patients who meet the enrollment criteria were randomized 1:1 to either the BIS group or the OAA/S group. In the BIS group, the anesthesiologist set the target controlled infusion(TCI)parameters according to the patient's height, weight, gender and age. The initial plasma target concentration was set to 1.5 ug/ml, and the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the BIS value at 45-60. In the OAA/S group, the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the OAA/S value at 1 point.
Patients who meet the enrollment criteria were randomized 1:1 to either the BIS group or the OAA/S group. In the BIS group, the anesthesiologist set the target controlled infusion (TCI) parameters according to the patient's height, weight, gender and age. The initial plasma target concentration was set to 1.5 ug/ml, and the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the BIS value at 45-60. In the OAA/S group, the target concentration would be increased or decreased 0.5 ug/ml every two minutes to maintain the OAA/S value at 1 point. Body movement, the time of gastroscopy, endoscopist satisfaction scores to sedation, the propofol consumption during gastroscopy and the time to awake were be recorded. In addition, the event of the respiration and circulation suppression during the gastroscopy were recorded. Atropine 0.3 mg was injected intravenously if bradycardia occurred (heart rate <50 beats/min), M-hydroxyamine 0.3 mg was injected intravenously if hypotension (mean arterial pressure<65 mmHg), Ephedrine 3 mg was injected if bradycardia and hypotension occured. Patients would receive face mask-assisted ventilation if the Spo2 dropped below 90% or respiratory frequency was lower than 8 breaths/min during the gastroscopy. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01350050 -
Topical Pharyngeal Anesthesia With Articaine for Gastroscopy
|
Phase 4 | |
Completed |
NCT04292496 -
Anastomotic Leak Testing in Gastrectomy
|
N/A | |
Completed |
NCT05219136 -
Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol
|
N/A | |
Completed |
NCT04150237 -
Using Simulation to Ensure Basic Competence in Gastroscopy
|
||
Completed |
NCT05012527 -
Retrospective Review of Gastrointestinal System Endoscopy Procedures
|
||
Completed |
NCT05504434 -
Performance of a Single-use Gastroscope (aScope Gastro) for Esophagogastroduodenoscopy
|
N/A | |
Recruiting |
NCT05965921 -
Real-life Prospective Evaluation of Computer-aided Detection (CAD) of Barrett's Neoplasia
|
||
Completed |
NCT02576340 -
Spasmolytic in Upper Gastrointestinal Endoscopy
|
Phase 4 | |
Completed |
NCT01154530 -
Chlorhexidine Mouthwash and Bacterial Contamination During Endoscopy
|
N/A | |
Completed |
NCT04247399 -
Simulation-assisted Teaching in Learning Gastroscopy
|
N/A | |
Not yet recruiting |
NCT05693298 -
High Flow Nasal Cannula in Patients Undergoing Gastroscopy
|
N/A | |
Completed |
NCT04682821 -
The Research of AI Assistant Gastroscope Training
|
N/A | |
Completed |
NCT01151228 -
Bedside Ultrasound Assessment of Gastric Content and Volume
|
N/A | |
Recruiting |
NCT04641455 -
Use of Mucolytic Solution Before Upper Endoscopy
|
N/A | |
Not yet recruiting |
NCT06303037 -
Effect of Esketamine on 95% Induction Dose of Remimazolam
|
Phase 4 |